Replimune Group, Inc. — Director's Dealing 2019

Dec 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2019-12-20

Reporting Person: Esposito Pamela (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-20	Common Stock	M	25700	$1.75	Acquired	112700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-20	Employee Stock Option (right to buy)	$1.75	M	25700	Disposed	2026-03-01	Common Stock (25700)	Direct

Footnotes

F1: The reporting person was granted a stock option to acquire 196,162 shares of the Issuer's common stock, subject to vesting. Approximately 183,878 shares underlying the stock option have vested as of the date hereof, with the remaining shares underlying the stock option to vest in 3 approximately equal monthly installments as of the 29th of each month.